RCM - RCMテクノロジ―ズ （R1 RCM Inc.）

The following slide deck was published by R1 RCM Inc.

R1 RCM Inc. found using ticker (RCM) now have 8 analysts covering the stock with the consensus suggesting a rating of ''Buy''. The range between the high target price and low target price is between 35 and 28 with the average target price sitting at 32.25. With the stocks previous close at 21.04 this would imply there is a potential upside of 53.3%. The 50 day MA is 24.8 while the 200 day moving average is 23.42. The company has a market cap of $6,299m. Find out more information at: https://www.r1rcm.com [stock_market_widget type="chart" template="basic" color="green" assets="RCM" range="6mo" interval="1d" axes="true" cursor="true" api="yf"] The potential market cap would be $9,655m based on the market concensus. R1 RCM Inc. provides revenue cycle management (RCM) for healthcare providers in the United States. The company offers end-to-end RCM services to manage their revenue cycle operations that encompass patient registration, insurance and benefit verification, medical treatment documentation and coding, bill preparation, and collections from patients and payers.

RCM Technologies’ Q1 FY22 revenues soared by 84% year-on-year while EBITDA quintupled to $9.3 million. Click here to learn more about RCM stock.

R1 RCM Inc. (NASDAQ:NASDAQ:RCM) Q1 2022 Earnings Conference Call May 09, 2022 08:00 AM ET Company Participants Atif Rahim - Head, Investor Relations Joe Flanagan - President & Chief…

R1 RCM Inc. with ticker code (RCM) now have 9 analysts in total covering the stock. The consensus rating is ''Buy''. The range between the high target price and low target price is between 35 and 27.5 calculating the average target price we see 31.72. With the stocks previous close at 25.79 this now indicates there is a potential upside of 23.0%. There is a 50 day moving average of 23.75 and the 200 day MA is 22.66. The company has a market capitalisation of $7,340m. Find out more information at: https://www.r1rcm.com [stock_market_widget type="chart" template="basic" color="green" assets=RCM" range="6mo" interval="1d" axes="true" cursor="true" api="yf"] The potential market cap would be $9,028m based on the market concensus. R1 RCM Inc. provides revenue cycle management (RCM) for healthcare providers in the United States. The company offers end-to-end RCM services to manage their revenue cycle operations that encompass patient registration, insurance and benefit verification, medical treatment documentation and coding, bill preparation, and collections from patients and payers.

MURRAY, Utah, Feb. 17, 2022 (GLOBE NEWSWIRE) -- R1 RCM Inc. (NASDAQ: RCM), a leading provider of technology-driven solutions that transform the patient experience and financial performance of healthcare providers, today announced results for the three months and year ended December 31, 2021.

Companies Reporting Before The Bell • Palantir Technologies (NYSE: PLTR ) is estimated to report quarterly earnings at $0.04 per share on revenue of $417.69 million. • Organon (NYSE: OGN ) is expected to report quarterly earnings at $1.24 per share on revenue of $1.57 billion. • Perella Weinberg Partners (NASDAQ: PWP ) is likely to report quarterly earnings at $0.30 per share on revenue of $193.75 million. • Navios Maritime Partners (NYSE: NMM ) is estimated to report quarterly earnings at $4.35 per share on revenue of $272.59 million. • Portland General Electric (NYSE: POR ) is likely to report quarterly earnings at $0.76 per share on revenue of $533.13 million. • Frontline (NYSE: FRO ) is estimated to report quarterly earnings at $0.13 per share on revenue of $111.30 million. • R1 RCM (NASDAQ: RCM ) is estimated to report quarterly earnings at $0.11 per share on revenue of $399.26 million. • Fiverr International (NYSE: FVRR ) is likely to report quarterly earnings at $0.04 per share on revenue of $76.

R1 RCM (NASDAQ:RCM) is scheduled to announce Q4 earnings results on Thursday, February 17th, before market open.The consensus EPS Estimate is $0.14 (-44.0% Y/Y) and the consensus…

MURRAY, Utah, Feb. 14, 2022 (GLOBE NEWSWIRE) -- R1 RCM Inc. (NASDAQ: RCM), a leading provider of technology-driven solutions that transform the patient experience and financial performance of healthcare providers, today announced its management team will present at the SVB Leerink 11th Annual Global Healthcare Conference on Friday, February 18, 2022 at 1:00 pm ET.

Robert W. Baird Stick to Their Buy Rating for R1 RCM

MURRAY, Utah, Aug. 31, 2021 (GLOBE NEWSWIRE) -- R1 RCM Inc. (NASDAQ: RCM ), a leading provider of technology-driven solutions that transform the patient experience and financial performance of healthcare providers, today announced its management team will present at three upcoming investor conferences: The Morgan Stanley 19th Annual Global Healthcare Conference on Thursday, September 9 Full story available on Benzinga.com